Strategic Advocates »

Gilead Sciences shares owned by Strategic Advocates

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.5k 32 139.38
2025-12-31 $18k 150 122.99
2025-09-30 $12k 106 111.39

More positions owned by Strategic Advocates

Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr Gold Shares Etf (GLD)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
State Street Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Fidelity Low Volatility Factor Etf Etf (FDLO)
Nvidia Corporation Stock (NVDA)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Vanguard Consumer Staples Etf Etf (VDC)
Vanguard Energy Etf Etf (VDE)
Ishares U.s. Healthcare Etf Etf (IYH)

View all positions for Strategic Advocates

Top funds holding Gilead Sciences

Vanguard Group
BlackRock
Vanguard Capital Management
FMR
State Street Corporation
Capital World Investors
Vanguard Portfolio Management
Geode Capital Management
Capital Research Global Investors
Dodge & Cox
Morgan Stanley
Bank of America Corporation
Wellington Management Company
Invesco
Bank of New York Mellon

View all funds holding Gilead Sciences